Mechanisms of aluminium neurotoxicity in oxidative stress-induced ...
Mechanisms of aluminium neurotoxicity in oxidative stress-induced ... Mechanisms of aluminium neurotoxicity in oxidative stress-induced ...
CHAPTER 1 RESULTS Effects of 6-OHDA administration on TBARS concentration 92 As shown in Fig. 1, the intrastriatal administration of 6 μg of 6-OHDA in the right striatum caused a significant and progressive increase of TBARS concentration in both right striatum (F(7,24) = 51.73, p < 0.001) and right ventral midbrain (F(7,24) = 72.81, p < 0.001), obtaining a peak-effect 48 h after the injection. Although, the increase in the right striatum was significant at 5 min versus 1 h for ventral midbrain, the augmentation observed after 48 h was higher in the right ventral midbrain (+83%) than in the right striatum (+26%). At 7-day post-injection, the values returned to those of the controls. A significant and progressive increase in the TBARS concentration was also observed in the contralateral side, affecting again to both left striatum (F(7,24) = 10.39, p < 0.001) and left ventral midbrain (F(7,24) = 6.30, p < 0.001). The peak-effect was also observed at 48 h, but the increase was lower (+23% in the left striatum and +26% in the left ventral midbrain). At 7-day post-injection the values returned to the concentrations found in the corresponding controls. Effects of 6-OHDA administration on PCC The PCC also exhibited a significant and progressive time course increase (Fig. 2), which affected both right striatum (F(7,24) = 57.55, p < 0.001) and right ventral midbrain (F(7,24) = 54.76, p < 0.001). In this case, the increase observed in PCC was not significant till 1-h post-injection. However, the peak-effect was observed once again 48 h after injection, and higher in the right ventral midbrain (+42%) than in the right striatum (+38%). A significant and progressive increase in PCC was also observed in the contralateral side, affecting to both left striatum (F(7,24) = 5.95, p < 0.001) and left ventral midbrain (F(7,24) = 3.48, p < 0.05). However, in this case, although the peak- effect was also observed at 48-h post-injection, the increase found was lower (+12% in
CHAPTER 1 the left striatum and +11% in the left ventral midbrain). The corresponding concentrations achieved values close to those found in the controls at 7-day post- injection. Effects of 6-OHDA administration on PTC Figure 3 shows the time-course of the changes observed for PTC in proteins following 6-OHDA administration. As can be seen, a significant and progressive reduction in PTC was found in both right striatum (F(7,24) = 5.06, p < 0.05) and right ventral midbrain (F(7,24) = 25.87, p < 0.001). The maximal decrease for both right striatum (–7%) and right ventral midbrain (–20%) was found at 24 h. Although the peak-effect did not happen at the same time for both TBARS concentration and PCC, the value obtained for PTC at 24 h was not significantly different when compared with that observed 48-h post-injection. The PTC in the contralateral side only exhibited a significant reduction in the left ventral midbrain (F(7,24) = 5.06, p < 0.05), because the changes observed in the left striatum did not reach statistical significance (F(7,24) = 0.87, p > 0.05). Once again, the minimum value found in the left striatum for PTC was observed 24-h post-injection and the decrease was of –8%, a value lower than that found in the ipsilateral side. No significant differences were found when the value obtained at 24 h was compared with that obtained at 48 h. 93
- Page 65 and 66: DA metabolism as a source of ROS IN
- Page 67 and 68: Contribution of oxidative and nitro
- Page 69 and 70: Excitotoxicity INTRODUCTION Glutama
- Page 71 and 72: INTRODUCTION al. 1996, Cicchetti et
- Page 73 and 74: Experimental models of PD INTRODUCT
- Page 75 and 76: INTRODUCTION induce selective DAerg
- Page 77 and 78: ALUMINIUM General features INTRODUC
- Page 79 and 80: INTRODUCTION Varying amounts of alu
- Page 81 and 82: INTRODUCTION and antiperspirants co
- Page 83 and 84: INTRODUCTION approximately 3% of al
- Page 85 and 86: Excretion INTRODUCTION As insoluble
- Page 87 and 88: INTRODUCTION 3.5 mg may be increase
- Page 89 and 90: INTRODUCTION Oteiza 1999), non-iron
- Page 91 and 92: Aluminium as a cell membrane menace
- Page 93 and 94: INTRODUCTION mobilization of Ca 2+
- Page 95: Aluminium impairs neurotransmission
- Page 99 and 100: AIMS OF THE PRESENT THESIS The main
- Page 101: OBJETIVOS
- Page 104 and 105: OBJETIVOS 3) Evaluar de forma preci
- Page 107: CHAPTER 1 Time-course of brain oxid
- Page 110 and 111: CHAPTER 1 INTRODUCTION 86 6-OHDA (2
- Page 112 and 113: CHAPTER 1 MATERIALS AND METHODS Che
- Page 114 and 115: CHAPTER 1 followed by centrifugatio
- Page 118 and 119: CHAPTER 1 DISCUSSION 94 As shown by
- Page 120 and 121: CHAPTER 1 strategies or to study th
- Page 122 and 123: CHAPTER 1 Fig. 2 Changes in PCC in
- Page 125: CHAPTER 2
- Page 129 and 130: ABSTRACT CHAPTER 2 In the present w
- Page 131 and 132: MATERIALS AND METHODS Chemicals CHA
- Page 133 and 134: CHAPTER 2 atomization used were 1,5
- Page 135 and 136: DISCUSSION CHAPTER 2 Aluminium ente
- Page 137: Table 1. Graphite furnace programme
- Page 141: CHAPTER 3 Brain oxidative stress an
- Page 144 and 145: CHAPTER 3 INTRODUCTION 120 The huma
- Page 146 and 147: CHAPTER 3 MATERIALS AND METHODS Che
- Page 148 and 149: CHAPTER 3 1:15 for hippocampus and
- Page 150 and 151: CHAPTER 3 initially incorporated to
- Page 152 and 153: CHAPTER 3 RESULTS In vivo effects o
- Page 154 and 155: CHAPTER 3 Effects of aluminium admi
- Page 156 and 157: CHAPTER 3 DISCUSSION 132 Aluminium
- Page 158 and 159: CHAPTER 3 hippocampus, showed simil
- Page 160 and 161: CHAPTER 3 assume that the distinct
- Page 162 and 163: CHAPTER 3 Fig. 1 Levels of TBARS (A
- Page 164 and 165: CHAPTER 3 Fig. 2 Enzyme activity of
CHAPTER 1<br />
the left striatum and +11% <strong>in</strong> the left ventral midbra<strong>in</strong>). The correspond<strong>in</strong>g<br />
concentrations achieved values close to those found <strong>in</strong> the controls at 7-day post-<br />
<strong>in</strong>jection.<br />
Effects <strong>of</strong> 6-OHDA adm<strong>in</strong>istration on PTC<br />
Figure 3 shows the time-course <strong>of</strong> the changes observed for PTC <strong>in</strong> prote<strong>in</strong>s<br />
follow<strong>in</strong>g 6-OHDA adm<strong>in</strong>istration. As can be seen, a significant and progressive<br />
reduction <strong>in</strong> PTC was found <strong>in</strong> both right striatum (F(7,24) = 5.06, p < 0.05) and right<br />
ventral midbra<strong>in</strong> (F(7,24) = 25.87, p < 0.001). The maximal decrease for both right<br />
striatum (–7%) and right ventral midbra<strong>in</strong> (–20%) was found at 24 h. Although the<br />
peak-effect did not happen at the same time for both TBARS concentration and PCC,<br />
the value obta<strong>in</strong>ed for PTC at 24 h was not significantly different when compared with<br />
that observed 48-h post-<strong>in</strong>jection. The PTC <strong>in</strong> the contralateral side only exhibited a<br />
significant reduction <strong>in</strong> the left ventral midbra<strong>in</strong> (F(7,24) = 5.06, p < 0.05), because the<br />
changes observed <strong>in</strong> the left striatum did not reach statistical significance (F(7,24) =<br />
0.87, p > 0.05). Once aga<strong>in</strong>, the m<strong>in</strong>imum value found <strong>in</strong> the left striatum for PTC was<br />
observed 24-h post-<strong>in</strong>jection and the decrease was <strong>of</strong> –8%, a value lower than that<br />
found <strong>in</strong> the ipsilateral side. No significant differences were found when the value<br />
obta<strong>in</strong>ed at 24 h was compared with that obta<strong>in</strong>ed at 48 h.<br />
93